The Opportunity

Lowell is developing an anticoagulant for critically ill patients in the ICU.

Niyad™

Niyad™ is an anticoagulant for patients with sudden kidney failure in the ICU.

Meet Lowell

Meet and learn more about the Lowell Therapeutics™ team.